| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/07/2009 | CN101549100A Traditional Chinese medicine for treating cancer |
| 10/07/2009 | CN101549069A Application and production method of anti-lymphoma drug |
| 10/07/2009 | CN101549048A Effective component of vervain and preparation method thereof |
| 10/07/2009 | CN101549047A Five-element health-preserving capsule |
| 10/07/2009 | CN101549042A Method for extracting amino acid from potatoes and application of extract thereof |
| 10/07/2009 | CN101549036A Effective component of morinda officinalis and preparation method thereof |
| 10/07/2009 | CN101549032A Drug composition with the effect of anti-lung cancer and application in preparing anti-lung cancer drug |
| 10/07/2009 | CN101549025A Traditional Chinese medicine for treating cancer |
| 10/07/2009 | CN101549004A Effective components of seed of cowherb and preparation method thereof |
| 10/07/2009 | CN101549001A Effective component of artemisia leaves and preparation method thereof |
| 10/07/2009 | CN101549000A Effective component of cynanchum atratum and preparation method thereof |
| 10/07/2009 | CN101548995A Application of Viscum album extract as NF-kB inhibitor |
| 10/07/2009 | CN101548974A Compound having fluorescent characteristic and anti-cancer activity, preparation thereof and application thereof |
| 10/07/2009 | CN101548967A Pharmaceutical composition |
| 10/07/2009 | CN101548951A Hydroxycamptothecin nano lipidosome for injections and method for preparing same |
| 10/07/2009 | CN101548950A Tripterine nanometer lipid injection and method for preparing same |
| 10/07/2009 | CN101548949A Paclitaxel nanoemulsion injection |
| 10/07/2009 | CN101548948A Anti-cancer medicine sustained-release agent containing 5-FU potentiating agent |
| 10/07/2009 | CN101548947A Docetaxel nanometer lipid injection, preparation method and purpose thereof |
| 10/07/2009 | CN101548946A Curcumin nano-lipid injection liquid, preparation method and application thereof |
| 10/07/2009 | CN101548692A Flour containing anticancer foods |
| 10/07/2009 | CN100547082C Primer, segment and method for identifying sex of air potato |
| 10/07/2009 | CN100547075C Her-2/neu DNA vaccine having anti-cancer activity |
| 10/07/2009 | CN100547000C Hornet anti-bacterial peptide, its preparing method and use |
| 10/07/2009 | CN100546977C New compounds for the inhibition of rotamases and use thereof |
| 10/07/2009 | CN100546976C Nitroaniline-based alkylating agents and their use as prodrugs |
| 10/07/2009 | CN100546658C Ligand of polyoxyethylene of containing target peptide toward to liver cancer and its synthesis method |
| 10/07/2009 | CN100546654C Use of chitosan quaternary ammonium salt/rectorite nano composite material |
| 10/07/2009 | CN100546649C Ultrasonic microvesicle as immuno adjuvant and vaccine carrier |
| 10/07/2009 | CN100546621C Novel use of known medicine |
| 10/07/2009 | CN100546619C Extraction of garlic volatile oil |
| 10/07/2009 | CN100546602C Anti-cancer compound preparation of giant knotweed, Tengli root and thinleaf adina root and its making method and use |
| 10/07/2009 | CN100546601C Anti-cancer extracts from thinleaf adina root and its making method and use |
| 10/07/2009 | CN100546593C A method for preparing purified extract from wild ginseng showing anticancer activity and the composition comprising the same |
| 10/07/2009 | CN100546591C Water extract of Gecko Radix Actinidiae in use for treating liver cancer |
| 10/07/2009 | CN100546590C Anti-cancer Tengli root extract and its making method and use |
| 10/07/2009 | CN100546586C Application of yew amylose in pharmacy |
| 10/07/2009 | CN100546579C Nanometer microsphere of temozolomide polylactic acid and its preparation and preparing method therefor |
| 10/07/2009 | CN100546578C Anticancer medicine composition and its application in preparing anticancer medicine |
| 10/07/2009 | CN100546575C Medicine composition containing red clover prime and prunetin and its medicinal application |
| 10/06/2009 | US7598419 Such as N-(Cyanoacetyl)-3,4-dimethoxybenzylamide |
| 10/06/2009 | US7598418 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction |
| 10/06/2009 | US7598382 Immonomoderators; viricides; anticancer agents; for example, 2-Butyl-1-isobutyl-7-(thiophen-3-yl)-1H-imidazo[4,5-c]quinolin-4-amine; use of these compounds for inducing or inhibiting cytokine biosynthesis in animals |
| 10/06/2009 | US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 10/06/2009 | US7598294 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy |
| 10/06/2009 | US7598293 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 10/06/2009 | US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 10/06/2009 | US7598272 Kinase inhibitors |
| 10/06/2009 | US7598270 Diagnostic agent for detecting colorectal carcinoma by detecting presence of HERG potassium channel in tissue biopsy of human colon or rectum or in lymph nodes, which are free of HERG potassium channels in healthy human; 4-[1-[2-(6-methyl-2-pyridinyl)ethyl-4-piperidin-yl]carbonyl]methanesulfoanilide |
| 10/06/2009 | US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents |
| 10/06/2009 | US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 10/06/2009 | US7598258 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor |
| 10/06/2009 | US7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 10/06/2009 | US7598253 Reverse-turn mimetics and methods relating thereto |
| 10/06/2009 | US7598245 Pyruvate dehydrogenase kinase, c-KIT, cyclin-dependent kinases, Janus kinases, FLT3 kinase, AUR-2 kinase, tyrosine kinase; 1-(2-amino-4-pyridyl)-3-phenylaminotriazoles; combination therapy with antiallergens, immunomodulators, antiproliferative agents; Alzheimer's, Parkinson's, Multiple Sclerosis, asthma |
| 10/06/2009 | US7598244 (S)-1-(3-ethoxy-1-methylpropyl)-3-[7-(3,4-methylenedioxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea; preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease |
| 10/06/2009 | US7598242 Compounds for the treatment of inflammatory disorders |
| 10/06/2009 | US7598239 Side effect reduction; antiproliferative agents; schizophrenia |
| 10/06/2009 | US7598237 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators |
| 10/06/2009 | US7598232 Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders |
| 10/06/2009 | US7598225 Generation of immune response to prostate-specific antigen (PSA) |
| 10/06/2009 | US7598056 Factor VII or VIIA-like molecules |
| 10/06/2009 | US7598045 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer |
| 10/06/2009 | US7598042 Early prostate cancer antigens (EPCA), polynucleotide sequences encoding them, and their use |
| 10/06/2009 | US7597905 Hollow nanoparticle for use in the transfer of biopolymer into cells |
| 10/06/2009 | US7597894 Antigen presenting cells and dendritic cells; inducing immunology response |
| 10/06/2009 | US7597875 Diaminedioxime radiometal complexes |
| 10/06/2009 | CA2427617C Medicinal compositions for concomitant use as anticancer agent |
| 10/06/2009 | CA2416194C Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin d3 to increase bone strength |
| 10/06/2009 | CA2381348C Lck-derived peptides activating ctls |
| 10/06/2009 | CA2376596C Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies |
| 10/06/2009 | CA2328076C Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 10/06/2009 | CA2321116C Pharmaceutical formulation of a didemnin compound |
| 10/06/2009 | CA2284689C Animal model for evaluation of vaccines |
| 10/06/2009 | CA2207779C Carcinoma treatment |
| 10/04/2009 | CA2625304A1 Androgen receptor related methods for treating bladder cancer |
| 10/01/2009 | WO2009121042A1 Quinazoline derivatives and methods of treatment |
| 10/01/2009 | WO2009120922A2 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 10/01/2009 | WO2009120905A2 Immunoglobulin and/or toll-like receptor proteins associated with myelogenous haematological proliferative disorders and uses thereof |
| 10/01/2009 | WO2009120899A2 G coupled protein receptors associated with myelogenous haematological proliferative disorders and uses thereof |
| 10/01/2009 | WO2009120849A1 2-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof |
| 10/01/2009 | WO2009120826A1 2-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof |
| 10/01/2009 | WO2009120815A2 Therapeutic compositions and methods |
| 10/01/2009 | WO2009120769A1 Human anti-mesothelin monoclonal antibodies |
| 10/01/2009 | WO2009120712A2 Compositions and methods for diagnosing and treating melanoma |
| 10/01/2009 | WO2009120697A2 Method and compositions for treatment of cancer |
| 10/01/2009 | WO2009120358A1 Oligomer-nitrogenous base conjugates |
| 10/01/2009 | WO2009120162A1 'ua' orion ' substance |
| 10/01/2009 | WO2009120094A2 Substituted pyrimidines and triazines and their use in cancer therapy |
| 10/01/2009 | WO2009119880A1 Substituted pyrazole derivatives and use thereof |
| 10/01/2009 | WO2009119874A1 Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 10/01/2009 | WO2009119793A1 Method for production of transfected cell |
| 10/01/2009 | WO2009119776A1 Fused heterocyclic derivative and use thereof |
| 10/01/2009 | WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 10/01/2009 | WO2009119692A1 Novel glycolipid and use thereof |
| 10/01/2009 | WO2009119667A1 Helicobacter pylori GROWTH INHIBITOR AND METHOD FOR PRODUCTION THEREOF |
| 10/01/2009 | WO2009119662A1 Peptide capable of inducing autophagic cell death |
| 10/01/2009 | WO2009119455A1 Cancer cell motility and cancer cell infiltration inhibitor |
| 10/01/2009 | WO2009119105A1 METHOD FOR IN VITRO PREPARATION OF GPIbα+GPV+GPVI+ PLATELET |
| 10/01/2009 | WO2009119092A1 Anti-tumor agent comprising cytidine derivative and carboplatin |